Research Interests
- Pharmaceutical business model
- Corporate influence over medical practice and research
- Public drug coverage policy / “pharmacare”
Our team members are acknowledged experts in a wide variety of pharmaceutical policy topics. We are available to speak about issues related to our expertise.